Sutro Biopharma, Inc. (STRO) cash on hand

Cash · fiscal 2025
$141.43M

Sutro Biopharma, Inc. (STRO) held cash of $141.43M at the end of fiscal 2025 (December 31, 2025). That is 55.4% lower than the $316.90M of fiscal 2024. Figures as of 17 Nov 2026, 22:07 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$141.43M
Change on fiscal 2024
−55.4%
Highest on record
$375.62Mfiscal 2023
Lowest on record
$141.43Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Sutro Biopharma, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $375.62M in fiscal 2023 and the lowest $141.43M in fiscal 2025.

History · 4 fiscal years

Cash by fiscal year

Sutro Biopharma, Inc. cash on hand, year by year

Sutro Biopharma, Inc. (STRO) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$141.43M 55.4% down
2024$316.90M 15.6% down
2023$375.62M 12.3% up
2022$334.36M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on STRO

Sutro Biopharma, Inc., figure by figure

Sutro Biopharma, Inc. (STRO) overview: price, valuation and scorecard

Sutro Biopharma, Inc. cash on hand: questions and answers

How much cash does Sutro Biopharma, Inc. have?

Sutro Biopharma, Inc. (STRO) held cash of $141.43M at the end of fiscal 2025 (December 31, 2025). That is 55.4% lower than the $316.90M of fiscal 2024.

What are the highest and lowest cash figures on record for Sutro Biopharma, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $375.62M in fiscal 2023 and the lowest $141.43M in fiscal 2025.

How is Sutro Biopharma, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sutro Biopharma, Inc. (STRO) cash on hand”, data as of 17 November 2026. https://funkfolio.com/stock/STRO/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.